Thursday Apr 17
Teva, Pfizer settle patent lawsuit over painkiller Celebrex
Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.
Ask The Pharmacist: A dozen ways to reduce chronic pain
Question: I have chronic pain and take ibuprofen daily plus hydrocodone and celecoxib.
Wall St. Cheat Sheet
Supreme Court Studies Generic Drug Question: How Will Patients Fare?
Perhaps not as attention-grabbing as the health care industry's struggle to adapt to the changes brought by the Affordable Care Act , its efforts to deal with what is known as the patent cliff is nevertheless a hugely important narrative for pharmaceutical companies.
The Daily Advertiser
Phil Kerpen: Attacking cancer patients doesn't fix Obamacare
Kennedy tells us about breast cancer survivor Ginny Mason, who could no longer afford her arthritis medication under Obamacare.
The green revolution
The healing compounds found in green tea promote longevity and help prevent, and treat, a host of diseases and disorders Legend has it that the cup that cheers, which lovers of the brew refer to as our next best potion, after water - or, nature's most wholesome beverage - owes its origin to a freak incident between knowledge and providence.
The Motley Fool
Dividend Derby: AbbVie Vs. Pfizer
Drug companies are staples in dividend investors' portfolios thanks to their predictable demand and solid cash flow.
Worcester Telegram & Gazette
Obamacare plans bring hefty fees for certain drugs
Breast cancer survivor Ginny Mason was thrilled to get health coverage under the Affordable Care Act despite her pre-existing condition.